5-Bromo-4-chloro-3-indolyl-beta-D-glucuronide cyclohexylammonium salt
Synonyms
114162-64-0 [RN] 5-Bromo-4-chloro-3-indolyl β-D-glucuronide cyclohexylammonium salt 5-Bromo-4-chloro-3-indolyl-β-D-glucuronic acid cyclohexylammonium salt 5-Bromo-4-chloro-3-indolyl-β-D-glucuronide cyclohexylammonium salt Cyclohexanamine – 5-bromo-4-chloro-1H-indol-3-yl β-D-glucopyranosiduronic acid (1:1) Cyclohexanaminium 5-bromo-4-chloro-1H-indol-3-yl β-D-glucopyranosiduronate [ACD/IUPAC Name] Cyclohexanaminium-5-brom-4-chlor-1H-indol-3-yl-β-D-glucopyranosiduronat [German] [ACD/IUPAC Name] X-glucuronide CHA salt β-D-Glucopyranosiduronic acid, 5-bromo-4-chloro-1H-indol-3-yl, compd. with cyclohexanamine (1:1) [ACD/Index Name] (2S,3S,4S,6S,5R)-6-(5-bromo-4-chloroindol-3-yloxy)-3,4,5-trihydroxy-2H-3,4,5,6-tetrahydropyran-2-carboxylic acid, cyclohexylamine 129541-41-9 [RN] 18656-96-7 [RN] 5-Bromo-4-chloro-3-indolyl-b-D-glucuronide cyclohexyl ammonium salt 5-BROMO-4-CHLORO-3-INDOLYL-β-D-GLUCOPYRANOSIDE 5-Bromo-4-chloro-3-indolyl-β-D-glucuronide cyclohexyl ammonium salt 5-Bromo-4-chloro-3-indolyl-β-D-glucuronide, cyclohexylammonium salt 5-Bromo-4-chloro-3-indolyl-β-D-glucuronidecyclohexylammonium salt Cyclohexanamine (2S,3S,4S,5R,6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate Cyclohexanaminium (2S,3S,4S,5R,6S)-6-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylate MFCD00058543 [MDL number] QB-5915 X-glcA X-GlcA CHA salt, X-Gluc CHA salt X-GlcA CHA salt ; X-Gluc CHA salt ; XGLUC Cyclohexylammonium Salt X-GLUC XGLUC Cyclohexylammonium Salt
Molecular Structure
structure of 5-Bromo-4-chloro-3-indolyl-beta-D-glucuronide cyclohexylammonium salt CAS 114162-64-0
Fill out our inquiry form and one of our experts will be in touch with you shortly (Please change screen to horizontal for complete browsing if you are checking Watson on your mobile phone).
andD purpose. It may be toxic or hazardous, and should be handled only by qualified individuals trained in laboratory procedures. The buyer will be responsible to warn and inform any person that may be in contact with the product of the potential risks and hazards, as well as to ensure that purchase, use and disposal of the product comply with local laws and regulations.
GSK1349572,1051375-16-6,GSK1349572;(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;S/GSK1349572 (GSK1349572);Dolutegravir;GSK1349572(dolutegravir);S/GSK1349572;dolutegravir/GSK1349572/S-349572;Dolutegravir API […]